Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PRDS, THRX, SLGC, ACRS, HIMS, and represent 69.80% of Foresite Capital Management V's stock portfolio.
  • Added to shares of these 2 stocks: HIMS (+$5.3M), ENTA.
  • Started 1 new stock positions in ENTA.
  • Reduced shares in these 4 stocks: SLGC (-$13M), HLTH, CGEM, ADGI.
  • Foresite Capital Management V was a net seller of stock by $-12M.
  • Foresite Capital Management V has $245M in assets under management (AUM), dropping by -39.84%.
  • Central Index Key (CIK): 0001792206

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Companies in the Foresite Capital Management V portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pardes Biosciences (PRDS) 27.7 $68M 9.4M 7.22
Theseus Pharmaceuticals (THRX) 15.1 $37M 3.2M 11.53
Somalogic Com Cl A (SLGC) 12.2 $30M -30% 3.7M 8.02
Aclaris Therapeutics (ACRS) 8.9 $22M 1.3M 17.24
Hims & Hers Health Com Cl A (HIMS) 5.9 $14M +58% 2.7M 5.33
Adicet Bio (ACET) 5.5 $14M 680k 19.97
Quantum-Si Incorporated Com Cl A (QSI) 4.5 $11M 2.3M 4.68
Cullinan Oncology (CGEM) 4.2 $10M -13% 993k 10.47
Kinnate Biopharma (KNTE) 4.0 $9.9M 875k 11.26
Adagio Therapeutics (ADGI) 2.7 $6.5M -17% 1.4M 4.56
Compass Therapeutics (CMPX) 2.5 $6.0M 4.4M 1.37
Research Alliance Corp. II Com Cl A (RACB) 2.0 $4.9M 500k 9.76
Gemini Therapeutics (GMTX) 1.4 $3.4M 2.4M 1.39
Cue Health (HLTH) 1.3 $3.2M -57% 491k 6.45

Setup an alert

Foresite Capital Management V will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Enanta Pharmaceuticals (ENTA) 1.2 $3.0M NEW 42k 71.17
23andMe Holding Com Cl A (ME) 0.6 $1.6M 407k 3.83
Pharvaris N V (PHVS) 0.3 $619k 34k 18.13

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020